Quisovalimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Quisovalimab Usage And Synthesis

Uses

Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. Quisovalimab can be used in COVID-19 acute respiratory distress syndrome and other studies[1].

References

[1] David S Perlin, et al. Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS. mSphere. 2020 Aug 12;5(4):e00699-20. DOI:10.1128/mSphere.00699-20

Quisovalimab(2427667-03-4)Related Product Information

• Merpentan
• Frexalimab
• Barzolvolimab
• Rulonilimab
• Vanucizumab
• Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer
• EV2-7
• Voxalatamab
• Disitamab
• Vepsitamab